Germline and Rearranged VH and VL Gene Segments Used in Anti-Rh(D) H and L Chains
Family . | Antibody* . | Isotype . | Probable† Germline V Gene . | Nucleotide Differences . | Next closest† Germline V Gene . | Nucleotide Differences . | Closest† Rearranged V Gene . | Nucleotide Differences . |
---|---|---|---|---|---|---|---|---|
VH1 | 25F5 | IgG1/k | V1-2 | 8 | DP-8 | 9 | 20P3 fetal | 7 |
VH1 | 13E10 | IgG1/λ | V1-2 | 12 | DP-8 | 13 | 20P3 fetal | 13 |
VH1 | 21H9 | IgG1/k | DP-25 | 11 | VI-3 | 16 | LE 1-42 fetal | 11 |
VH1 | 28E4 | IgG1/k | DP-7 | 14 | HG3 | 15 | H20C3H fetal | 16 |
VH3 | 24A5 | IgG3/λ | hv3019b9 | 5 | P6 | 7 | FL13-48 fetal | 5 |
VH3 | 26C1 | IgG3/k | hv3019b9 | 5 | P6 | 7 | FL13-48 fetal | 5 |
VH3 | 19A5 | IgG1/k | hv3019b9 | 17 | P6 | 19 | FL13-48 fetal | 17 |
VH3 | 43F10 | IgG1/k | hv3019b9 | 16 | P6 | 18 | FL13-48 fetal | 16 |
VH3 | 13D2 | IgG3/k | hv3019b13 | 9 | DP-46 | 10 | M74 fetal | 9 |
VH3 | 46E7 | IgG1/k | 3-21 | 16 | 3-48 | 20 | E54 fetal | 13 |
VkI | 26C1 | IgG3/k | L11 | 10 | A30 | 21 | 2E7 anti-platelet | 18 |
VkI | 13D2 | IgG3/k | 02 | 8 | L11 | 23 | 15a anti-i | 5 |
VkI | 21H9 | IgG1/k | 02 | 12 | L11 | 27 | 15a anti-i | 12 |
VkI | 43F10 | IgG1/k | 02 | 13 | L11 | 29 | 15a anti-i | 13 |
VkI | 46E7 | IgG1/k | L12a | 6 | HK102 | 10 | I.26 | 6 |
VkI | 25F5 | IgG1/k | L12a | 15 | HK102 | 19 | I.26 | 10 |
VkIII | 28E4 | IgG1/k | DPK21 | 2 | Vg | 19 | Z18330‡ | 2 |
VkIII | 19A5 | IgG1/k | Humkv325 | 7 | Humvk305 | 12 | T15-42 | 6 |
VλII | 13E10 | IgG1/λ | DPL-11 | 2 | DP-L10 | 16 | L25295‡ | 2 |
VλIV | 24A5 | IgG3/λ | IGLV3S1 | 12 | Vλ III.1 | 73 | E51 | 10 |
Family . | Antibody* . | Isotype . | Probable† Germline V Gene . | Nucleotide Differences . | Next closest† Germline V Gene . | Nucleotide Differences . | Closest† Rearranged V Gene . | Nucleotide Differences . |
---|---|---|---|---|---|---|---|---|
VH1 | 25F5 | IgG1/k | V1-2 | 8 | DP-8 | 9 | 20P3 fetal | 7 |
VH1 | 13E10 | IgG1/λ | V1-2 | 12 | DP-8 | 13 | 20P3 fetal | 13 |
VH1 | 21H9 | IgG1/k | DP-25 | 11 | VI-3 | 16 | LE 1-42 fetal | 11 |
VH1 | 28E4 | IgG1/k | DP-7 | 14 | HG3 | 15 | H20C3H fetal | 16 |
VH3 | 24A5 | IgG3/λ | hv3019b9 | 5 | P6 | 7 | FL13-48 fetal | 5 |
VH3 | 26C1 | IgG3/k | hv3019b9 | 5 | P6 | 7 | FL13-48 fetal | 5 |
VH3 | 19A5 | IgG1/k | hv3019b9 | 17 | P6 | 19 | FL13-48 fetal | 17 |
VH3 | 43F10 | IgG1/k | hv3019b9 | 16 | P6 | 18 | FL13-48 fetal | 16 |
VH3 | 13D2 | IgG3/k | hv3019b13 | 9 | DP-46 | 10 | M74 fetal | 9 |
VH3 | 46E7 | IgG1/k | 3-21 | 16 | 3-48 | 20 | E54 fetal | 13 |
VkI | 26C1 | IgG3/k | L11 | 10 | A30 | 21 | 2E7 anti-platelet | 18 |
VkI | 13D2 | IgG3/k | 02 | 8 | L11 | 23 | 15a anti-i | 5 |
VkI | 21H9 | IgG1/k | 02 | 12 | L11 | 27 | 15a anti-i | 12 |
VkI | 43F10 | IgG1/k | 02 | 13 | L11 | 29 | 15a anti-i | 13 |
VkI | 46E7 | IgG1/k | L12a | 6 | HK102 | 10 | I.26 | 6 |
VkI | 25F5 | IgG1/k | L12a | 15 | HK102 | 19 | I.26 | 10 |
VkIII | 28E4 | IgG1/k | DPK21 | 2 | Vg | 19 | Z18330‡ | 2 |
VkIII | 19A5 | IgG1/k | Humkv325 | 7 | Humvk305 | 12 | T15-42 | 6 |
VλII | 13E10 | IgG1/λ | DPL-11 | 2 | DP-L10 | 16 | L25295‡ | 2 |
VλIV | 24A5 | IgG3/λ | IGLV3S1 | 12 | Vλ III.1 | 73 | E51 | 10 |
21H9 and 19A5 MoAbs were derived of the peripheral blood lymphocytes (PBLs) of donor LA and the other MoAbs of the PBLs of donor AR.
References for germline and rearranged genes are as follows: Germline VH: VI-2 and VI-321; DP-25, DP7, DP-8 and DP-4622; hv3019b9 and hv3019b1323; 3-21 and 3-4824; HG325. Rearranged VH 20P326; LE 1-4227; H20C3H28; FL13-4829; M74,30 and E5431. Germline VL: L1132; 0233; L12a and A3034; DPK2135; Humkv32536; HK10237; Humvk30538; Vg39; DPL-11 and DPL-1040; IGLV3S141 and VλIII.1.42 Rearranged VL: 2E743; 15a44; I.2645; T15-4246; L25295,47 and E51.48
Genbank accession number.